Literature DB >> 29270632

Association of Dietary Fatty Acid Intake With Glaucoma in the United States.

Ye Elaine Wang1, Victoria L Tseng1, Fei Yu1,2, Joseph Caprioli1, Anne L Coleman1,3.   

Abstract

Importance: Identifying whether an association exists between daily dietary polyunsaturated fatty acid (PUFA) consumption and the prevalence of glaucoma in the United States may provide modifiable dietary risk factors for the development of glaucoma. Objective: To analyze the association between glaucoma and daily dietary intake of PUFAs, including ω-3 fatty acids, in the US population. Design, Setting, and Participants: Data from 3865 participants in the National Health and Nutrition Examination Survey (NHANES) 2005-2008 database who were 40 years or older, had participated in the vision health and dietary intake questionnaires, and had available results from laboratory tests and eye examinations that included frequency-doubling technology visual field loss detection tests and optic disc photographs were included. Data collection was performed by NHANES from 2005 to 2006. Data for the present study were downloaded from their database May 1 to 30, 2017. Data analyses were performed from June 1 to October 1, 2017. Exposures: Daily dietary intake of PUFAs, including ω-3 fatty acids. Main Outcomes and Measures: Prevalence of glaucoma in the United States as defined using the Rotterdam criteria, which included a combination of optic cupping or asymmetry and visual field defect results.
Results: Of the 83 643 392 weighted survey participants included in this cross-sectional study, 43 660 327 (52.2%) were women and 3 076 410 (3.7%) met our criteria for having glaucoma. Compared with participants without glaucoma, those with glaucoma were older (mean [SE] age, 61.4 [0.8] vs 53.7 [0.4] years; P < .001). Increased levels of daily dietary intake of eicosapentaenoic acid (odds ratio [OR], 0.06; 95% CI, 0.00-0.73) and docosahexaenoic acid (OR, 0.06; 95% CI, 0.01-0.87) were associated with significantly lower odds of having glaucoma. However, participants with daily total dietary PUFA intake levels in the second (OR, 2.84; 95% CI, 1.39-5.79) and third (OR, 2.97; 95% CI, 1.08-8.15) quartiles showed significantly increased odds of meeting our criteria for a diagnosis of glaucoma. Conclusions and Relevance: Increased daily dietary consumption levels of eicosapentaenoic acid and docosahexaenoic acid were associated with lower likelihood of glaucomatous optic neuropathy. However, consumption levels of total PUFAs in the higher quartiles were associated with a higher risk of glaucoma, which may have resulted from the relative intakes of ω-6 and ω-3 fatty acids and other confounding comorbidities. This study also hypothesizes that increasing the proportion of dietary ω-3 consumption levels while controlling overall daily PUFA intake may be protective against glaucoma. However, longitudinal studies or randomized clinical trials are needed to assess these hypotheses.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29270632      PMCID: PMC5838715          DOI: 10.1001/jamaophthalmol.2017.5702

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  28 in total

1.  Dietary omega 3 fatty acids decrease intraocular pressure with age by increasing aqueous outflow.

Authors:  Christine T O Nguyen; Bang V Bui; Andrew J Sinclair; Algis J Vingrys
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-02       Impact factor: 4.799

2.  Intraocular pressure reduction with a fixed treatment protocol in the Early Manifest Glaucoma Trial.

Authors:  Anders Heijl; M Cristina Leske; Leslie Hyman; Zhongming Yang; Boel Bengtsson
Journal:  Acta Ophthalmol       Date:  2010-03-17       Impact factor: 3.761

3.  Nerve fiber layer defects with normal visual fields. Do normal optic disc and normal visual field indicate absence of glaucomatous abnormality?

Authors:  A Tuulonen; J Lehtola; P J Airaksinen
Journal:  Ophthalmology       Date:  1993-05       Impact factor: 12.079

4.  Comparison of methods to evaluate the optic nerve head and nerve fiber layer for glaucomatous change.

Authors:  J Caprioli; B Prum; T Zeyen
Journal:  Am J Ophthalmol       Date:  1996-06       Impact factor: 5.258

5.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

6.  Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss.

Authors:  A Sommer; J Katz; H A Quigley; N R Miller; A L Robin; R C Richter; K A Witt
Journal:  Arch Ophthalmol       Date:  1991-01

7.  An evaluation of optic disc and nerve fiber layer examinations in monitoring progression of early glaucoma damage.

Authors:  H A Quigley; J Katz; R J Derick; D Gilbert; A Sommer
Journal:  Ophthalmology       Date:  1992-01       Impact factor: 12.079

Review 8.  Omega-3 fatty acids and inflammatory processes.

Authors:  Philip C Calder
Journal:  Nutrients       Date:  2010-03-18       Impact factor: 6.706

9.  Lipid composition of the human eye: are red blood cells a good mirror of retinal and optic nerve fatty acids?

Authors:  Niyazi Acar; Olivier Berdeaux; Stéphane Grégoire; Stéphanie Cabaret; Lucy Martine; Philippe Gain; Gilles Thuret; Catherine P Creuzot-Garcher; Alain M Bron; Lionel Bretillon
Journal:  PLoS One       Date:  2012-04-09       Impact factor: 3.240

Review 10.  Effect of dietary Fatty acids on human lipoprotein metabolism: a comprehensive update.

Authors:  Esther M M Ooi; Gerald F Watts; Theodore W K Ng; P Hugh R Barrett
Journal:  Nutrients       Date:  2015-06-02       Impact factor: 5.717

View more
  7 in total

Review 1.  Targeting Diet and Exercise for Neuroprotection and Neurorecovery in Glaucoma.

Authors:  James R Tribble; Flora Hui; Melissa Jöe; Katharina Bell; Vicki Chrysostomou; Jonathan G Crowston; Pete A Williams
Journal:  Cells       Date:  2021-02-01       Impact factor: 6.600

Review 2.  Diet, Oxidative Stress, and Blood Serum Nutrients in Various Types of Glaucoma: A Systematic Review.

Authors:  Maryla Młynarczyk; Martyna Falkowska; Zuzanna Micun; Iwona Obuchowska; Jan Kochanowicz; Katarzyna Socha; Joanna Konopińska
Journal:  Nutrients       Date:  2022-03-29       Impact factor: 5.717

3.  Oral Omega-3 Supplementation Lowers Intraocular Pressure in Normotensive Adults.

Authors:  Laura Elizabeth Downie; Algis Jonas Vingrys
Journal:  Transl Vis Sci Technol       Date:  2018-05-01       Impact factor: 3.283

4.  Effects of Oral Supplementation with Docosahexaenoic Acid (DHA) plus Antioxidants in Pseudoexfoliative Glaucoma: A 6-Month Open-Label Randomized Trial.

Authors:  Stéphanie Romeo Villadóniga; Elena Rodríguez García; Olatz Sagastagoia Epelde; M Dolores Álvarez Díaz; Joan Carles Domingo Pedrol
Journal:  J Ophthalmol       Date:  2018-09-17       Impact factor: 1.909

5.  Plasma fatty acids and primary open-angle glaucoma in the elderly: the Montrachet population-based study.

Authors:  Alicia Chemaly; Louis Arnould; Alassane Seydou; Pierre-Henry Gabrielle; Florian Baudin; Niyazi Acar; Catherine Creuzot-Garcher
Journal:  BMC Ophthalmol       Date:  2021-03-23       Impact factor: 2.209

Review 6.  The Pathomechanism, Antioxidant Biomarkers, and Treatment of Oxidative Stress-Related Eye Diseases.

Authors:  Yi-Jen Hsueh; Yen-Ning Chen; Yu-Ting Tsao; Chao-Min Cheng; Wei-Chi Wu; Hung-Chi Chen
Journal:  Int J Mol Sci       Date:  2022-01-23       Impact factor: 5.923

Review 7.  Natural Products: Evidence for Neuroprotection to Be Exploited in Glaucoma.

Authors:  Annagrazia Adornetto; Laura Rombolà; Luigi Antonio Morrone; Carlo Nucci; Maria Tiziana Corasaniti; Giacinto Bagetta; Rossella Russo
Journal:  Nutrients       Date:  2020-10-16       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.